Fei Wu

3.1k total citations
147 papers, 2.0k citations indexed

About

Fei Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fei Wu has authored 147 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Molecular Biology, 39 papers in Cancer Research and 27 papers in Oncology. Recurrent topics in Fei Wu's work include Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (15 papers) and MicroRNA in disease regulation (13 papers). Fei Wu is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), RNA modifications and cancer (15 papers) and MicroRNA in disease regulation (13 papers). Fei Wu collaborates with scholars based in China, United States and Netherlands. Fei Wu's co-authors include Tao Luo, Yuan-Jin Guo, Chen Huang, Ji-Hua Dong, Huarong Li, Lei Zhao, Lijun Jia, Han Li, Chen Huang and Huan Liu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Physical Chemistry.

In The Last Decade

Fei Wu

127 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Wu China 24 1.0k 466 216 214 209 147 2.0k
Zhuorui Xie United States 10 1.2k 1.2× 338 0.7× 231 1.1× 184 0.9× 308 1.5× 18 2.0k
Olga Sukocheva Australia 26 1.2k 1.2× 304 0.7× 261 1.2× 171 0.8× 160 0.8× 71 2.0k
John Erol Evangelista United States 11 1.3k 1.3× 338 0.7× 248 1.1× 196 0.9× 333 1.6× 22 2.2k
Eryk Kropiwnicki United States 8 1.4k 1.4× 395 0.8× 281 1.3× 223 1.0× 408 2.0× 10 2.4k
Ying Ni United States 25 1.2k 1.2× 434 0.9× 305 1.4× 165 0.8× 169 0.8× 114 2.1k
Pan Wang China 28 1.1k 1.1× 660 1.4× 432 2.0× 175 0.8× 287 1.4× 179 2.2k
Xingyu Chen China 22 889 0.9× 332 0.7× 256 1.2× 282 1.3× 250 1.2× 127 1.7k
Megan L. Wojciechowicz United States 10 1.5k 1.5× 429 0.9× 301 1.4× 233 1.1× 435 2.1× 13 2.6k

Countries citing papers authored by Fei Wu

Since Specialization
Citations

This map shows the geographic impact of Fei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Wu more than expected).

Fields of papers citing papers by Fei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Wu. The network helps show where Fei Wu may publish in the future.

Co-authorship network of co-authors of Fei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Wu. A scholar is included among the top collaborators of Fei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Wu. Fei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Fei, Hongmei Lin, Shengjun Jiang, et al.. (2025). Experimental validation of RNA interference technologies for improved control of barber’s pole worm. Veterinary Research. 56(1). 194–194.
2.
Wang, Weiwei, Yinbin Zhang, Jia Li, et al.. (2024). Establishment of patient‐derived organoids for guiding personalized therapies in breast cancer patients. International Journal of Cancer. 155(2). 324–338. 12 indexed citations
3.
Wu, Fei, Ruijie Yin, Min Yuan, et al.. (2024). Critical role of apoptosis in MeCP2‐mediated epithelial–mesenchymal transition of ARPE‐19 cells. Journal of Cellular Physiology. 239(12). e31429–e31429.
4.
Wu, Fei, Jiaqi Xu, Meng Liu, et al.. (2024). TRIM8 promotes ovarian cancer proliferation and migration by targeting VDAC2 for ubiquitination and degradation. Cancer Medicine. 13(11). e7396–e7396. 3 indexed citations
5.
Liu, Mengjie, Chaofan Li, Jingkun Qu, et al.. (2023). Baicalein enhances immune response in TNBC by inhibiting leptin expression of adipocytes. Cancer Science. 114(10). 3834–3847. 12 indexed citations
6.
Qu, Jingkun, Chaofan Li, Yusheng Wang, et al.. (2023). Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients. Journal of Clinical Medicine. 12(9). 3097–3097. 8 indexed citations
8.
9.
Zhao, Mingna, Ling-Fei Zhang, Xianzhou Zhang, et al.. (2023). A novel microRNA-182/Interleukin-8 regulatory axis controls osteolytic bone metastasis of lung cancer. Cell Death and Disease. 14(5). 298–298. 13 indexed citations
10.
Wu, Fei, et al.. (2023). MeCP2-Induced Alternations of Transcript Levels and m6A Methylation in Human Retinal Pigment Epithelium Cells. ACS Omega. 8(50). 47964–47973. 3 indexed citations
11.
Qin, Yannan, Haiqing Zhang, Bo Guo, et al.. (2022). Whole-Transcriptome Analysis of Serum L1CAM-Captured Extracellular Vesicles Reveals Neural and Glycosylation Changes in Autism Spectrum Disorder. Journal of Molecular Neuroscience. 72(6). 1274–1292. 19 indexed citations
12.
Lu, Mingkuan, Shuo Wang, Chuandong Cai, et al.. (2022). Pyrrolidine Dithiocarbamate-loaded Electrospun Membranes for Peritendinous Anti-adhesion through Inhibition of the Nuclear Factor-κB Pathway. Acta Biomaterialia. 155. 333–346. 21 indexed citations
14.
Li, Jia, Fei Wu, Chaofan Li, et al.. (2022). The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer. Frontiers in Genetics. 13. 977322–977322. 35 indexed citations
15.
Wu, Fei, Rinse de Boer, Arjen M. Krikken, et al.. (2020). Pex24 and Pex32 are required to tether peroxisomes to the ER for organelle biogenesis, positioning and segregation in yeast. Journal of Cell Science. 133(16). 22 indexed citations
16.
Xu, Yuzi, Yiming Lv, Fei Wu, et al.. (2020). Identification of Four Pathological Stage‐Relevant Genes in Association with Progression and Prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International. 2020(1). 2137319–2137319. 11 indexed citations
17.
Gong, Shipeng, et al.. (2018). Roflumilast enhances cisplatin‐sensitivity and reverses cisplatin‐resistance of ovarian cancer cells via cAMP/PKA/CREB‐FtMt signalling axis. Cell Proliferation. 51(5). e12474–e12474. 24 indexed citations
18.
Wu, Fei, et al.. (2016). HIV-1 infection in early human placenta in vitro: Effects of Tumor Necrosis Factor (TNF-α) and Interleukins IL-1 and IL-6. North American Journal of Medicine and Science. 9(4). 1 indexed citations
19.
Wu, Fei. (2013). Design of Width of Panchromatic Spectra of High Resolution Optical Remote Sensing Camera Based on Pansharpening. 1 indexed citations
20.
Xing, Rui, Fei Wu, & Robert W. Mason. (1998). Control of breast tumor cell growth using a targeted cysteine protease inhibitor.. PubMed. 58(5). 904–9. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026